Bacterial infections after implant surgical procedures are a complication observed in many surgeries to treat bone injuries or diseases. Bacteria can attach to the surface of the implant producing biofilms, and if treatment with antibiotics does not work, further surgery is necessary to remove the infected implant. Among the biomaterials for bone implants, bioceramics based on calcium phosphates (CaPs) such as β-TCP stand out, due to their chemical similarity with bone and high bioresorbability. β-TCP has the characteristic of easily accommodating in its crystalline structure reasonable amounts of doping elements, such as monovalent and trivalent ions, which makes it an efficient transporter of drugs, molecules, and therapeutic ions The objective of this work was the incorporation of bioactive glass (BG 45S5) via sol-gel and silver nanoparticles (Ag-NPs) in β-TCP scaffolds, aiming to confer antimicrobial activity to the scaffolds, without prejudice to biocompatibility. XRD and FT-IR analysis indicated structural changes after the incorporation of BG 45S5 and Ag-NPs in β-TCP scaffolds, and these compounds induced the partial transformation of the β-TCP phase into α-TCP phase and the formation of sodium-calcium silicates and silver silicates. The FT-IR spectra showed characteristic bands of α-TCP after incorporation, in addition to the predominant bands of β-TCP. Biocompatibility after incorporation of BG 45S5 was improved, with a significant increase in cell viability. After the incorporation of Ag-NPs, cell viability was maintained at an acceptable level, no cytotoxic behavior was observed, and the scaffolds showed antibacterial and antifungal activity. The results indicate that BG 45S5 and the Ag-NPs incorporated showed a synergistic behavior, conferring antimicrobial activity to the scaffolds without compromising biocompatibility, showing great potential for applicability in tissue engineering.
Sensors based on the surface plasmon resonance (SPR) technique are useful devices to detect and monitor interactions between biomolecules in real-time. SPR is a label-free method that monitors the variation of reflectivity of a biochip composed of a metal-coated glass prism and can be applied in several areas, such as biotechnology, food safety and clinical diagnosis. In the last years, several researchers have proven the efficiency of metallic nanoparticles (NPs) in the enhancement of SPR signal. This feature allowed the detection of biomolecules at very low concentration. Aiming to further enhance SPR signal towards the detection of proteins at low concentration and by a simple procedure, the present work compared the performance of gold and platinum bimetallic NPs (AuPtNPs) with that of monometallic gold NPs (AuNPs) in the enhancement of SPR signal. In order to evaluate the NPs, protein peanut agglutin (PNA) was used as target analyte and anti-PNA antibody was used as sensing molecule. Firstly NPs were functionalized with anti-PNA antibody and incubated with a solution containing PNA. Then, the NPs bound to PNA were injected into the SPR equipment containing a biochip previously modified with anti-PNA antibody. The results demonstrated that the AuPtNPs provided a 91-fold increase compared to the direct detection of free PNA in solution. In comparison with AuNPs, the signal generated by AuPtNPs was about 4 times higher. This encouraging result indicated that the application of bimetallic NPs may be a better strategy to further enhance sensitivity of SPR biosensors and could drive the development of new strategies that are not only simple, but also able to detect proteins at low concentrations, which is of great importance, especially in clinical diagnostics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.